Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.8721 | 100 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 14.1353 | 100 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 14.0608 | 100 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 14.6026 | 100 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 14.1536 | 100 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.7506 | 100 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.6437 | 100 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 14.0779 | 100 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 14.0523 | 100 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 14.0154 | 100 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.9274 | 100 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 14.04 | 100 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.9912 | 100 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 14.1105 | 100 |